Best Oncologist in Gurugram: Top Cancer Specialists at Medanta, Fortis and Beyond

44+ years of experience

Dr. Ashok K. Vaid is a distinguished medical oncologist and stem cell transplant specialist with more than four decades of clinical experience. He currently serves as Chairman, Medical Oncology, Hematology and Stem Cell Transplant at the Medanta Cancer Institute, Gurgaon — one of India's largest cancer programmes. Dr. Vaid established one of the largest stem cell transplant programmes in the private sector in north India. His clinical interests centre on cancer genomics, immunotherapy guidance, precision onco-therapeutics, dendritic cell therapy, and stem cell transplantation. He has performed and supervised some of the earliest bone marrow transplants in the country, including the first 25 BMTs done at his earlier institution. He earned his Doctor of Medicine (DM) in Medical Oncology from Tamil Nadu Dr. MGR Medical University, Chennai, and has authored several peer-reviewed publications. Dr. Vaid has served as Principal Investigator for more than 50 international and national clinical studies, and is a registered postgraduate teacher with the National Board of Examinations and a panel examiner for super-specialty Medical Oncology. In recognition of his exceptional contribution to medicine, the Government of India conferred upon him the prestigious Padma Shri Award in 2009.

17+ years of experience

Dr. Ankur Bahl is the Principal Director of Medical Oncology at Fortis Memorial Research Institute in Gurugram, bringing over 17 years of specialised clinical experience in cancer treatment. A graduate of Maulana Azad Medical College, Delhi, where he completed both his MBBS and MD in Medicine, Dr. Bahl furthered his expertise by obtaining his DM in Medical Oncology from the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi. He has also completed a specialized course on Adverse Drug Reactions, Drug Interactions, and Pharmacovigilance at the University of Oxford, UK, strengthening his evidence-based approach to cancer care. Dr. Bahl's clinical depth encompasses the full spectrum of medical oncology, including chemotherapy for solid tumours, neoadjuvant and adjuvant chemotherapy protocols, immunotherapy using immune checkpoint inhibitors, targeted molecular therapies, and hormonal treatment for breast cancer. He is recognised as the lead author of the largest real-world Indian dataset on targeted therapy with Cetuximab in head and neck cancer, acute myeloid leukaemia treatment, and Human Papillomavirus epidemiology in the Indian population—publications that have shaped understanding of cancer patterns and treatment efficacy in the region. His commitment to evidence-based oncology is evident through his active participation in tumour boards, master classes, and workshops across India and internationally. Dr. Bahl treats a substantial international patient cohort, welcoming patients from the Gulf Cooperation Council states, African nations, and South Asian countries seeking advanced oncological care. His fluency in English and Hindi enables seamless communication with diverse patient backgrounds. He provides comprehensive supportive and palliative care alongside curative treatments, ensuring patients receive holistic management throughout their cancer journey. Fortis Memorial Research Institute, where Dr. Bahl practises, is a leading tertiary-care cancer centre in Gurugram with state-of-the-art infrastructure, dedicated oncology wards, advanced diagnostic and treatment facilities, and a strong international patient support team. The hospital maintains accreditation standards and offers integrated care with specialist nurses, nutritionists, and counsellors. International patients benefit from streamlined admission processes, translation services, and coordination of follow-up care. Dr. Bahl's position as Principal Director ensures that patients receive leadership-level oversight of their treatment strategy, with access to the latest clinical protocols and innovations in cancer therapy.

10+ years of experience

Dr. Ankur Mudgal is a Consultant in Medical Oncology at Medanta – The Medicity, Gurugram, one of India's leading multi-specialty healthcare institutions. With over 10 years of clinical experience in oncology, Dr. Mudgal has established himself as a compassionate and evidence-based practitioner dedicated to delivering personalized cancer care. He holds qualifications in MBBS, MD, and DNB, and has completed advanced training in immuno-oncology through a preceptorship conducted by the European Society of Medical Oncology in Singapore—a credential that reflects his commitment to staying at the forefront of modern cancer therapeutics. Dr. Mudgal's clinical expertise spans the full spectrum of systemic cancer treatment, including chemotherapy, targeted therapy, immunotherapy, and hormone therapy. He brings particular depth in managing breast, lung, gastrointestinal, and genitourinary malignancies. His special interest in immune checkpoint inhibitor therapy and precision oncology allows him to tailor treatment strategies to each patient's tumor biology and clinical context. Beyond curative approaches, Dr. Mudgal is equally invested in palliative care and geriatric oncology, ensuring that elderly patients and those with advanced disease receive compassionate, symptom-focused support alongside disease-modifying therapies. Dr. Mudgal regularly treats patients from across the Gulf region, Africa, and South Asia who seek specialized oncology care in India. His fluency in both English and Hindi, combined with his patient-centered philosophy, makes him accessible and reassuring to international patients navigating complex cancer diagnoses. He takes time to explain treatment options, potential outcomes, and quality-of-life considerations in clear, understandable terms, empowering families to make informed decisions about their care. Medanta – The Medicity in Gurugram is a 650-bed tertiary care facility with advanced oncology infrastructure, including state-of-the-art chemotherapy units, medical imaging, and dedicated palliative care teams. The hospital's multi-disciplinary tumor boards, robust infection control protocols, and international patient services make it an ideal destination for comprehensive cancer care. Patients benefit from seamless coordination with surgical oncology, radiation oncology, and supportive care specialists, ensuring holistic treatment journeys. For international patients considering cancer treatment in India, Dr. Mudgal offers evidence-based, compassionate care grounded in the latest advances in medical oncology. Whether seeking a second opinion, curative-intent treatment, or palliative support, patients can expect a thoughtful, personalized approach designed to optimize both disease control and quality of life.

8+ years of experience

Dr. Ashutosh Jain is an Associate Consultant in the Department of Medical Oncology at Fortis Memorial Research Institute in Gurgaon, bringing over 8 years of clinical expertise in comprehensive cancer care. He holds a DM in Medical Oncology alongside his MD and MBBS qualifications, positioning him as a fully trained medical oncologist with deep subspecialty knowledge. Dr. Jain has developed extensive clinical experience across a broad spectrum of malignancies, including breast cancer, lung cancer, gastrointestinal cancers, head and neck cancers, brain tumors, urological cancers, gynecological cancers, lymphomas, leukemias, and myelomas. His areas of clinical focus encompass chemotherapy for solid tumors, immunotherapy approaches, targeted molecular therapy, hormone therapy for breast cancer, and advanced stem cell transplantation. He is particularly skilled in adjuvant and neoadjuvant chemotherapy protocols, palliative care optimization, and both autologous and allogeneic bone marrow transplantation for hematologic malignancies. Throughout his career, Dr. Jain has been affiliated with several prestigious cancer centers, including the Tata Memorial Research Institute in Mumbai—one of India's leading oncology institutions—and Banaras Hindu University in Uttar Pradesh. His training at these elite centers has instilled a commitment to evidence-based practice and continuous advancement in cancer treatment paradigms. He actively engages in academic activities and research, ensuring his clinical practice reflects the latest advances in oncology. At Fortis Memorial Research Institute in Gurgaon, Dr. Jain provides patient-centered oncologic care to both local and international patients. The hospital is well-equipped with modern diagnostic and treatment facilities, making it a trusted destination for patients seeking specialized cancer care. International patients from the Gulf region, Africa, and across South Asia regularly travel to Gurgaon for consultation and treatment under his care, benefiting from the hospital's international patient support services and his fluency in English and Hindi. Dr. Jain's approach combines rigorous clinical judgment with compassionate patient communication. He takes time to explain complex treatment options, potential outcomes, and quality-of-life considerations, ensuring that patients make informed decisions aligned with their individual circumstances and values. For international patients, Gaf Healthcare facilitates seamless access to his expertise through remote consultations, comprehensive medical record review, and coordinated care planning.

35+ years of experience

Dr. Anil Dhar is the Clinical Director and Head of Medical Oncology at Marengo Asia Hospitals in Gurugram, bringing over 35 years of distinguished experience in managing solid tumors and malignancies. A post-doctoral fellow from the prestigious Tata Memorial Hospital in Mumbai, Dr. Dhar trained under some of India's leading oncologists and has spent his career advancing cancer care through evidence-based treatment strategies and compassionate patient management. Dr. Dhar specializes in chemotherapy for solid tumors, adjuvant and neoadjuvant regimens, targeted therapy, immunotherapy for advanced cancers, and hormone therapy for breast cancer. His clinical practice is informed by biomarker-based precision medicine, allowing him to tailor treatment to each patient's unique tumor profile. Throughout his career, he has treated over 35,000 patients and is recognized for his expertise in pediatric oncology and palliative care, ensuring comprehensive support across all stages of disease. He has mentored hundreds of medical and DNB oncology residents, shaping the next generation of cancer specialists across AFMC Pune, MUHS, Delhi University, and DNB programs nationally. Dr. Dhar has extensive experience welcoming international patients from the Gulf region, Africa, and beyond. He is fluent in English and Hindi, and his team at Marengo Asia Hospitals is experienced in coordinating care, visa assistance, and family counseling for overseas patients. His holistic approach extends beyond chemotherapy to include preventive oncology, cancer awareness education, long-term survivorship planning, and family support—ensuring patients receive coordinated, compassionate care throughout their cancer journey. Marengo Asia Hospitals in Gurugram is a accredited multispecialty facility well-equipped for complex oncology cases, with dedicated chemotherapy infusion centers, advanced diagnostic imaging, and dedicated international patient services. The hospital's location near Delhi and robust infrastructure make it an ideal destination for international patients seeking quality cancer care in India. Dr. Dhar's combination of military medical service experience, academic credentials, and patient-centered philosophy makes him a trusted choice for families seeking expert oncology care abroad.